Insulet Corporation

NASDAQ: PODD
$267.42
-$3.90 (-1.4%)
Closing price August 19, 2022
Wednesday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Amarin, CenturyLink, Legg Mason, Rackspace, Transocean and Valero Energy.
Cowen analysts point out that an estimated 300 million people have diabetes globally, and that number is expected to skyrocket to an astounding 500 million by 2035.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, March 21, 2014. The include Apple, Boeing, Exelon, Herbalife and Symantec.
Source: Jon OggInvestors frequently get to see the analyst upgrades and Buy ratings from Wall Street, but they often do not get to see when analyst downgrade stocks to when they say to sell a stock....
Diabetes is becoming an epidemic in the U.S. and the Western World.  The ties to obesity are often direct, so the potential treatments are often directly tied as well.  We did a recent dig down for...
Insulet (PODD) reported earnings well below Wall St. expectations and revised its forecast for the rest of the year down. The stock is set to open off today. According to the AP, "Insulet Corp....